Related Experiment Video
Updated: Nov 8, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer
Clare F Malone1,2,3, Neekesh V Dharia1,2,3,4, Guillaume Kugener2
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Researchers identified NXT1 as a lethal genetic dependency in neuroblastoma. Exploiting the NXT1-NXT2 paralog relationship offers a strategy to selectively eliminate the essential NXF1 protein in tumor cells, minimizing toxicity.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer dependency maps using CRISPR/Cas9 screens identify context-specific genetic vulnerabilities.
- Distinguishing cytostatic from cytotoxic gene effects is challenging with depletion screens.
Purpose of the Study:
- To identify selective and rapidly lethal genetic dependencies in MYCN-amplified neuroblastoma.
- To explore a novel synthetic lethality mechanism for targeted cancer therapy.
Main Methods:
- Utilized diverse functional genomic screening assays.
- Investigated the role of NXT1 and its paralog NXT2 in mRNA nuclear export.
- Examined the synthetic lethality between NXT1 and NXT2 through their interaction with NXF1.
Main Results:
- Identified NXT1 as a selective and lethal genetic dependency in MYCN-amplified neuroblastoma.
- Discovered a synthetic lethality mechanism involving NXT1, NXT2, and their common binding partner NXF1.
- NXF1 is essential and its loss is tolerated only when both NXT1 and NXT2 are absent.
Conclusions:
- NXT1 is a promising therapeutic target for neuroblastoma.
- Targeting the NXT1-NXT2 paralog relationship enables selective elimination of the essential NXF1 protein in tumor cells.
- This strategy offers a potential approach to overcome toxicity associated with direct targeting of essential proteins.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...